Skip to main content
Blog
Open App →

AIRESCAN Stock Review (13/2/2023)

Hi everyone.

On 13/02/2023, our system had provided a few picks and the results are as below:

DVN – (Sell)  – Profit

FUV – (Buy) – Price Not Done

CCRN – (Buy) – In the Market

Dell – (Buy) – Profit

All three major US indexes finished in the green on Monday, and passed the worst week of the year so far, as investors looked for clues on interest rate path in Fed officials’ latest comments while awaited the upcoming US inflation report due tomorrow. The Dow added almost 370 points on Monday, while the S&P 500 and Nasdaq 100 were up 1.1% and 1.4%, respectively.

Let’s review our stock picks on Monday.

A call for sell for ENPH which resulted in profit. Our system entered the market at $211.22 and made a call to profit at $208.50, which is our trailing stop loss.

Enphase Energy, Inc., together with its subsidiaries, designs, develops, manufactures, and sells home energy solutions for the solar photovoltaic industry in the United States and internationally. The company offers semiconductor-based microinverter, which converts energy at the individual solar module level, and combines with its proprietary networking and software technologies to provide energy monitoring and control services.

A call for buy for STER which did not enter the market. Our system put an order to enter the market at $11.65 but the price did not hit our EP and went upwards throughout the market.

Sterling Check Corp. provides technology-enabled background and identity verification services in the United States, Canada, Europe, the Middle East and Africa, and the Asia Pacific. The company offers identity verification services, such as telecom and device verification, identification document verification, facial recognition with biometric matching, social security number verification, and live video chat identification proofing; fingerprinting; background checks, including criminal record checks, sex offender registries, civil court records, motor vehicle and driving license records, executive investigations, credit reports, social media searches, and contingent workforce solutions; liens, judgments, and bankruptcies; and sanctions, risk, and compliance checks.

A call for buy for DSGN which resulted in profit. Our system entered the market at $6.93 and made a call to profit at $7.06, which is our trailing stop loss.

Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company’s portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function, eventually leading to neurological, cardiac, and metabolic dysfunction; and Myotonic Dystrophy Type-1 (DM1), a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs. 

A call for buy for AZUL which did not enter the market. Our system put an order to enter the market at $4.82 but the price did not hit our EP and went upwards throughout the market.

Azul S.A., together with its subsidiaries, provides passenger and cargo transportation services in Brazil. As of December 31, 2021, the company operated 850 daily departures to 125 destinations through a network of 259 non-stop routes with a fleet of 179 aircraft. It is also involved in the loyalty programs, travel packages, investment fund, logistics solutions, and aircraft financing activities. 

A call for buy for BLI which is still in the market. Our system picked this stock as a swing trade and it is currently trading below our EP in the market. Follow this stock for all status updates.

Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software.

A call for buy for PLBY which did not enter the market. Our system put an order to enter the market at $2.44 but the price did not hit our EP and went upwards throughout the market.

PLBY Group, Inc. operates as a pleasure and leisure company worldwide. The company operates through three segments: Licensing, Direct-to-Consumer, and Digital Subscriptions and Content. It offers sexual wellness products, such as products that enhance sexual experience, lingerie, bedroom accessories, intimates, and adult content; style and apparel products for men and women; gaming and lifestyle products, including digital casino and social games, and other home and hospitality offerings; and beauty and grooming products for men and women, such as skincare, haircare, bath and body, grooming, cosmetics, and fragrance. 

Stay tuned for more of our stock picks.

Want the next pick before it's written up?

AIRESCAN's AI publishes live recommendations in the app.

Open the app →